Placing infants on their backs for sleep can help reduce the risk of Sudden Infant Death Syndrome (SIDS). But a study by Yale School of Medicine researchers and their colleagues shows that while the practice helped reduce the incidence of SIDS, it has...
Socially isolated female rats develop more tumors—and tumors of a more deadly type—than rats living in a social group, according to researchers at Yale University and the University of Chicago.The dramatic increase in mammary tumors among isolated Norway...
Researchers from Yale University and Mirna Therapeutics, Inc., reversed the growth of lung tumors in mice using a naturally occurring tumor suppressor microRNA. The study reveals that a tiny bit of RNA may one day play a big role in cancer treatment, and...
Dr. Murat Gunel, the newly named Nixdorff-German Professor of Neurosurgery, specializes in the treatment of brain aneurysms and vascular malformations and is an expert on the molecular genetics of intracranial aneurysms and cavernous malformations.The...
Dr. David A. Hafler, newly designated as the inaugural Gilbert H. Glaser Professor of Neurology, is a leader in the effort to better understand the cause of multiple sclerosis (MS).The chief and chair of neurology at Yale-New Haven Hospital and the Yale...
Kevin A. Pelphrey, the recently appointed Harris Associate Professor of Child Psychiatry, specializes in research aimed at understanding the development of social cognition in children with and without autism spectrum disorders and other...
Yale Medical Group (YMG) and Yale Cancer Center (YCC) physicians are urging women not to change their breast cancer screening routines. Their recommendations come in the wake of a government task force report which reversed long accepted breast cancer...
When patients actively participate in choosing their medical treatments, they are less likely to opt for risky procedures, a Yale University study has found. The research appears in the December issue of Arthritis Care & Research.The 216 subjects of...
A new prognostic tool that can determine the risk of recurrence in melanoma patients has been developed by researchers at Yale Cancer Center. The technology, based on five proteins expressed in melanoma tissue, can classify patients into a low-risk group...
Continuing to regularly smoke or drink alcohol after a diagnosis of head and neck cancer increases a patient’s chance of dying, a Yale-led team of researchers has found. The study appears in the December issue of Cancer Epidemiology, Biomarkers &...